This Government Contract opportunity from Department Of Health And Human Services was posted on May 19, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Preclinical Efficacy and Safety Testing
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
This contract involves conducting both in vitro and in vivo experiments to evaluate the tumor-killing effectiveness, potential off-target effects, and overall safety profile of an optimized T-cell receptor (TCR) using clear cell renal cell carcinoma (ccRCC) models and xenografts. The studies aim to generate essential preclinical data to support further development of the TCR for therapeutic applications. Issued by the National Institutes of Health under the Department of Health and Human Services, the work will be performed in Bethesda. It is designated as a subcontract opportunity under NAICS code 541715, which pertains to research and development services. The solicitation was posted in May 2026 with a response deadline in early June 2026. The contract focuses on generating robust efficacy and safety data crucial for advancing the candidate therapy toward clinical evaluation.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
